Literature DB >> 164874

Pharmacological reversal of cholestasis-associated decrease in hepatic cytochrome P-450.

M Mackinnon, F Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 164874     DOI： 10.1016/0006-2952(75)90256-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.

Authors:  I N White; U Muller-Eberhard
Journal:  Biochem J       Date:  1977-07-15       Impact factor: 3.857

2.  Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.

Authors:  R A Willson; F E Hart; J T Hew
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

3.  Reversal by triton WR-1339 of ethynyloestradiol-induced hepatic cholesterol esterification.

Authors:  R A Davis; R Showalter; F Kern
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

4.  [Ethinyl estradiol and hepatocarcinogenesis. An experimental study].

Authors:  K de Heer; G Klöppel; H W Schreiber
Journal:  Langenbecks Arch Chir       Date:  1987
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.